首页> 美国卫生研究院文献>Nutrition Research and Practice >A standardized bamboo leaf extract inhibits monocyte adhesion to endothelial cells by modulating vascular cell adhesion protein-1
【2h】

A standardized bamboo leaf extract inhibits monocyte adhesion to endothelial cells by modulating vascular cell adhesion protein-1

机译:标准化的竹叶提取物通过调节血管细胞粘附蛋白-1抑制单核细胞与内皮细胞的粘附

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bamboo leaves (Phyllostachys pubescens Mazel ex J. Houz (Poacea)) have a long history of food and medical applications in Asia, including Japan and Korea. They have been used as a traditional medicine for centuries. We investigated the mechanism of anti-inflammatory activity of a bamboo leaf extract (BLE) on tumor necrosis factor-alpha (TNF-α)-induced monocyte adhesion in human umbilical vein endothelial cells (HUVECs). Exposure of HUVECs to BLE did not inhibit cell viability or cause morphological changes at concentrations ranging from 1 µg/ml to 1 mg/ml. Treatment with 0.1 mg/ml BLE caused 63% inhibition of monocyte adhesion in TNF-α-activated HUVECs, which was associated with 38.4% suppression of vascular cell adhesion molecule-1 expression. Furthermore, TNF-α-induced reactive oxygen species generation was decreased to 47.9% in BLE treated TNF-α-activated HUVECs. BLE (0.05 mg/ml) also caused about 50% inhibition of interleukin-6 secretion from lipopolysaccharide-stimulated monocyte. The results indicate that BLE may be clinically useful as an anti-inflammatory or anti-oxidant for human cardiovascular disease including atherosclerosis.
机译:竹叶(Phyllostachys pubescens Mazel ex J. Houz(Poacea))在亚洲(包括日本和韩国)的食品和医疗应用历史悠久。数百年来,它们一直被用作传统药物。我们研究了竹叶提取物(BLE)对肿瘤坏死因子-α(TNF-α)诱导的人脐静脉内皮细胞(HUVECs)单核细胞粘附的抗炎活性的机制。 HUVEC暴露于BLE浓度在1 µg / ml至1 mg / ml范围内均不会抑制细胞活力或引起形态变化。用0.1 mg / ml BLE处理可导致TNF-α激活的HUVEC中单核细胞粘附的抑制率达到63%,这与38.4%抑制血管细胞粘附分子1表达有关。此外,在BLE处理的TNF-α活化的HUVEC中,TNF-α诱导的活性氧的产生降低至47.9%。 BLE(0.05 mg / ml)还可抑制脂多糖刺激的单核细胞分泌白介素6约50%。结果表明,BLE可能在临床上可用作人类心血管疾病(包括动脉粥样硬化)的抗炎剂或抗氧化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号